重新回顾Janus激酶作为类风湿性疾病的分子药物点
1Bright College, Hankyong National University, Anseong, Republic of Korea.
Frontiers in medicine
|February 11, 2026
概括
简氏激酶 (JAK) 抑制剂对于治疗诸如类风湿性关节炎等自身免疫性疾病至关重要. 本综述探讨了JAK结构和抑制剂,并提出了开发下一代药物的策略,以克服耐药性.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 简氏激酶 (JAK) 信号转换器和转录激活器 (STAT) 途径调节重要细胞过程,包括免疫反应.
- JAK-STAT通路的调节失调与诸如类风湿性关节炎等自身免疫性疾病有关.
- 目前的JAK抑制剂针对异常信号,但耐药性需要新的治疗策略.
研究的目的:
- 审查JAK的结构特征,特别是活动地点.
- 要总结目前可用的JAK抑制剂用于类风湿性关节炎.
- 根据结构分析,提出开发下一代JAK抑制剂的策略.
主要方法:
- 简氏激酶 (JAK) 及其活性位点的结构分析.
- 审查现有的JAK抑制剂用于类风湿性关节炎.
- 对JAK抑制剂的结合方式的分析.
主要成果:
- 新兴的结构数据为设计选择性JAK抑制剂提供了机会.
- 几种JAK抑制剂已被批准用于类风湿性关节炎,具有描述的结合模式.
- 了解JAK结构是克服突变驱动抗性的关键.
结论:
- 需要下一代JAK抑制剂来解决抵抗机制.
- 对JAK及其抑制剂的结构洞察力可以指导开发更有效的疗法.
- 向抑制JAKs仍然是一个有前途的策略来管理自身免疫性疾病.
相关概念视频
Rheumatic Heart Disease I: Introduction
558
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
558
Rheumatic Heart Disease IV: Nursing Management
346
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
346
Rheumatic Heart Disease III: Medical Management
380
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
380
Protein Kinases and Phosphatases
15.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
667
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
667
Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K


